+284.9%
NSC vs THC
+1,813.2%
-1,528.4%
-44.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.6% | -0.3% | -1.3% | -1.6% |
| 7D | +2.5% | +1.0% | +1.5% | +2.3% |
| 30D | +1.7% | +5.3% | -3.6% | +0.7% |
| 3M | -2.6% | +7.1% | -9.7% | -3.9% |
| 6M | +6.4% | +46.0% | -39.6% | -1.0% |
| YTD | +15.5% | +43.9% | -28.5% | +7.1% |
| 1Y | +17.6% | +45.4% | -27.8% | +8.7% |
| 3Y | +75.0% | +421.3% | -346.3% | +25.5% |
| 5Y | +32.2% | +261.5% | -229.3% | -2.4% |
| All | +284.9% | +1,813.2% | -1,528.4% | +109.3% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling